SPINEO
SCREENING FOR SLEEP APNEA
at YOUR CARDIOLOGIST
Discover our online platform to help screening for obstructive sleep apnea-hypopnea syndrome (OSAHS) from a simple electrocardiogram sensor.
Sleep apnea syndrome
Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a disorder characterized by stops (apneas) or decreases in breathing (hypopnea) during sleep, caused by an obstruction of the upper airways. Inducing a restless sleep, the consequences can be multiple: daytime sleepiness, loss of productivity, industrial and traffic accidents, ...
Knowing that smoking, high blood pression and obesity can be aggravating factors, OSAHS is a major public health issue worldwide, and especially in France.
​
​
diagnosis
Whereas OSAHS affects 4% of the French population, only 20% of them are diagnosed. However, INSERM (French National Institute of Health and Medical Research) underlines that this figure is probably underestimated, due to a strong difference in symptoms from one patient to another. Moreover, recent studies have demonstrated that around 40% of patients consulting a cardiologist also suffer from sleep apnea syndrome.
​
The current diagnosis involves a sleep recording by polysomnography (night spent in a specialized institution, which records many physiological signals), or by nocturnal respiratory polygraphy (performed on an outpatient care). However, no OSHAS screening tool exists for cardiologists.
spineo innovation
NOVIGA has developed SPINEO : from a simple ECG recording, worn all night long by the patient, the embedded algorithm by SPINEO helps the cardiologist to perform a quick and simple OSAHS screening.
HOW does it work?
SPINEO workflow
Some key dates ...
2021
2019
CE marking of SPINEO.
2018
2016
Creation of NOVIGA.
Creation of SPINEO, embedding the algorithm.
PhD work at University of Lorraine on an algorithm for the detection of sleep apnea syndrome from an ECG signal.
patient comfort
Patients spend the night home, only wearing a simple ECG sensor.
Savings
2 in 1 : our solution allows the cardiologist to achieve its cardiac analysis along a screening for sleep apnea.
Time saving
SPINEO helps in the screening of OSAHS by highlighting interest zones in signals and therefore, facilitates exam reading.
​
Availability
SPINEO is available from any computer, 24/7.
SPINEO platform is a class I medical device manufactured in January 2021 by NOVIGA, which is not reimbursed by health insurance organizations. It allows, from Holter electrocardiograms, to provide an assistance for the diagnosis of sleep apnea syndrome, for healthcare professionals trained in this field. Please read carefully the instructions for use. SPINEO is an assistance in diagnosis and can in no way replace the advice of a trained healthcare professional. In case of discrepancy between the analysis results provided by SPINEO and the clinical context, it is recommended to perform additional medical exams, such as polysomnography. SPINEO is a regulated health product, which, under this regulation, bears CE marking.